# Nicox

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nicox-s-a

- Industry: Healthcare Specialists
- Headquarters: France
- Website: www.nicox.com
- Total disclosed funding: $2.5M
- Latest round: Seed (Jun 1, 1998)
- Investors on record: 1

## About

Based in France, and founded in 1996, Nicox SA is an ophthalmology company providing solutions for vision care. The company bears the ticker symbol of EPA: ALCOX. As of 2024, the company is headed by its CEO Gavin Spencer. In August 2016, Visufarma S.p.a, a portfolio company of GHO Capital acquired Nicox SA. 

 The company offers novel ophthalmic therapeutics for eye diseases. The firm solution range helps in maintaining vision as well as improving ocular health. The firm focus areas are Glaucoma, Allergic Conjunctivitis, dry eye disease, and many more.

## Funding rounds

- Seed, Jun 1, 1998, $2.5M — Sofinnova Partners

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Seed